XML 50 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2023
Stockholders’ Equity [Abstract]  
Schedule of Restricted Common Stock The Company’s activity in restricted Common Stock was as follows for the nine months ended September 30, 2023:
   Number
of shares		   Weighted
average
grant date
fair value		 
Non–vested at January 1, 2023   -   $- 
Granted   15,318   $9.15 
Vested   (15,318)  $9.15 
Non–vested at September 30, 2023   -   $  
The Company’s activity in RSUs was as follows for the nine months ended September 30, 2023:
   Number of
shares		   Weighted average
grant date
fair value		 
Non–vested at January 1, 2023   134,799   $28.74 
Granted   112,033   $14.02 
Vested   (74,786)  $29.93 
Forfeited   (11,411)  $13.65 
Non–vested at September 30, 2023   160,635   $18.99 
   Number of
shares		   Weighted average
grant date
fair value		 
Non–vested at January 1, 2023   -      
Granted   88,965   $9.62 
Vested   -      
Forfeited   -      
Non–vested at September 30, 2023   88,965   $9.62 
Schedule of Warrant Activity The Company’s warrant activity was as follows for the nine months ended September 30, 2023:
   Number of
Shares		   Weighted
Average
Exercise
Price (USD)		   Weighted
Average
Contractual
Life (years)		   Intrinsic
Value (USD)		 
Outstanding – January 1, 2023   2,003,649   $149.09    2.86   $- 
Outstanding – September 30, 2023   2,003,649   $149.09    2.11   $           - 
Exercisable – September 30, 2023   2,003,649   $149.09    2.11   $- 

 
Schedule of Fair Value of Series C Warrants in Connection The following assumptions were used to calculate the fair value of Series C Warrants in connection with the modifications:
   Original Series C
Warrants		   March 1,
2022
Modification		   November 7,
2022
Modification		 
Term (years)   3.8    5.0    3.1 
Stock price  $22.22   $22.22   $14.52 
Exercise price  $30.80   $30.80   $12.77 
Dividend yield   0.0%   0.0%   0.0%
Expected volatility   54.7%   50.8%   63.9%
Risk free interest rate   1.5%   1.5%   4.8%
Number of shares   455,867    455,867    455,867 
Aggregate fair value  $3,336,000   $3,648,000   $3,230,000 

 

The following assumptions were used to calculate the fair value of Series D Warrants in connection with the modifications:
   Original Series D
Warrants		   March 1,
2022
Modification		   November 7,
2022
Modification		 
Term (years)   3.8    3.8    3.1 
Stock price  $22.22   $22.22   $14.52 
Exercise price  $151.80   $151.80   $12.77 
Dividend yield   0.0%   0.0%   0.0%
Expected volatility   63.5%   50.8%   63.9%
Risk free interest rate   1.3%   1.6%   4.8%
Number of shares   111,321    111,321    111,321 
Aggregate fair value  $50,000   $138,000   $910,000